Reston, Va., Feb. 20, 2018 (Business Wire)-The Gastroenterology Group, PC, a gastroenterology practice based in Reston, Va., announces its expansion into clinical research by partnering with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients.
The Gastroenterology Group is now offering clinical trials, allowing it to introduce the latest advances in research to its patients. As a result, the clinic’s patients have access - in the convenience of the clinic’s office - to treatments they might not otherwise have. The Gastroenterology Group recognizes the importance of conducting clinical research for its patients and community and doing its part to advance health care around the world.
“As a practice on the forefront of medicine, we are pleased to be able to offer clinical trials as treatment options for our patients. This will give our patients access to novel therapies that they would otherwise not have,” said Emil E. Valle, M.D., of The Gastroenterology Group. “Expanding treatment options for conditions, such as inflammatory bowel disease, is extremely important to provide optimal care. It was Elligo’s unique approach of providing clinical trial infrastructure at no cost that made offering trials feasible. We look forward to being a part of the Elligo network.”
“Elligo is delighted to be working with The Gastroenterology Group to advance the care its physicians are offering to patients,” said John Potthoff, Ph.D., co-founder and CEO of Elligo Health Research. “We provide the personnel, processes, technology and infrastructure to make the clinical research process easier for clinics at no cost, so they can focus on taking care of patients.”
About The Gastroenterology Group, PC
At The Gastroenterology Group, we believe that each patient and doctor becomes a team for treating an individual's digestive problems. Our gastroenterologists spend most of their time listening to understand your concerns and to respond with the best treatment options for you. Our professional staff understands the importance of following up to make sure that problems are resolved and your health improves.
CONTACT:
Lea Studer
SCORR Marketing
402-366-1752
lea@scorrmarketing.com
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.